PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
16-Jan-2023 The Scottish Medicines Consortium recommends Merck’s TEPMETKO® (tepotinib) as the first oral MET inhibitor treatment option for advanced NSCLC adult patients with METex14 skipping alterations Merck
13-Jan-2023 Tower expands pharmaceutical corridors with new Singapore site Tower Cold Chain
12-Jan-2023 Novotech Acquires European CRO – Strengthens Global Operations Novotech
10-Jan-2023 More doctors joining the NHS as nearly 900 more specialty training posts announced by HEE Health Education England
06-Jan-2023 PM Society Training Courses – Start 2023 with some fresh education and personal development PM Society
14-Dec-2022 Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture  SAE Media Group
13-Dec-2022 Scottish Medicines Consortium (SMC) Extends Advice Accepting RINVOQ®▼(upadacitinib) For Treatment of Adults with Moderate Rheumatoid Arthritis AbbVie
06-Dec-2022 Olympus Announces the Inaugural Olympus Asia Pacific Innovation Program (OAIP) Olympus Corporation
08-Nov-2022 Interventional Oncology Market Report 2022: Trends, Market Size, Analysis 2026 Markets and Markets
27-Oct-2022 Registration is now open for RNA Therapeutics Conference 2023 SAE Media Group
27-Oct-2022 Co-Chairs from Aerie Pharmaceuticals & Santen Inc USA Invite Industry Experts to join Ophthalmic Drugs SAE Media Group
04-Oct-2022 Optimum Strategic Communications Hosts 14th Annual Healthcare Investor Conference Optimum Strategic Communications
03-Oct-2022 Envision Pharma Group appoints Head of Envision Value & Access Envision Pharma Group
23-Sep-2022 Envision Pharma Group appoints new CEO Envision Pharma Group
21-Sep-2022 Tower to bring the temperature of pharmaceutical logistics to CPhI Tower Cold Chain
20-Sep-2022 RNA Delivery and Therapeutics Company SiSaf Announces Autumn Conference Schedule SiSaf Ltd
18-Aug-2022 Inizio strengthens leadership team with two key appointments Inizio
09-Aug-2022 Continue to expect more Covid variants, state researchers Nazarbayev University
21-Jul-2022 F-star Therapeutics Announces a License Agreement with Takeda for a Novel Next-Generation Immuno-oncology Bispecific Antibody F-star Therapeutics
21-Jul-2022 Rhythm Pharmaceuticals Announces Early Access Authorization for Setmelanotide for Use in Patients with Bardet-Biedl Syndrome in France Rhythm Pharmaceuticals